Other News

Murj Launches Cardiac Device Data Management Platform at Heart Rhythm Society 2017

SANTA CRUZ, Calif.–(Business Wire)–Murj, Inc., a digital health company dedicated to helping clinicians streamline care for patients with implantable cardiac devices, today announced general availability of the company’s cloud-based, HIPAA-compliant application that consolidates data from all implantable cardiac device (CIED) types and manufacturers into an elegant, robust platform that delivers […]

Abbott (ABT) Announces CE Mark And First Use Of The World’s First Smartphone Compatible Insertable Cardiac Monitor

ABBOTT PARK, Ill., May 8, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. […]

Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

MUNICH, April 27, 2017 /PRNewswire/ — ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation Study adds to the growing Edoxaban Clinical Research Programme (ECRP) evaluating its use in a […]

Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium

By Business Wire,  May 04, 2017, 04:00:00 AM EDT OXFORDSHIRE, U.K.–(BUSINESS WIRE)– Lombard Medical, Inc. (NASDAQ:EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the 39th annual Charing […]

Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (NASDAQ: CSII): Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third quarter ended March 31, 2017. The company’s third-quarter revenues were $52.1 […]

Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017

MARLBOROUGH, Mass., May 3, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including two late-breaking clinical trials, that will be featured at the 38th Annual Scientific Sessions of the Heart Rhythm Society in Chicago on May 10-13. Notably, the post-market approval data collected on […]

Acutus Medical Snags FDA OK for AcQGuide Steerable Sheath

CARLSBAD, Calif.–(BUSINESS WIRE)–Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, today announced the FDA clearance of the AcQGuide™ Steerable Sheath. The company will also feature several international presentations highlighting the AcQMap® High Resolution Imaging and Mapping System at the Heart Rhythm Society’s […]

LivaNova (LIVN) Takes Out Caisson Interventional in $72 Million Deal

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has acquired the remaining outstanding interests in Caisson Interventional, LLC (“Caisson”), in support of LivaNova’s strategic growth initiatives. Based in Maple Grove, Minn., Caisson is a privately held clinical-stage medical device company focused on […]